Antiangiogenic drugs: current knowledge and new approaches to cancer therapy

Journal of Pharmaceutical Sciences
Jose L Mauriz, Javier González-Gallego

Abstract

Angiogenesis--process of new blood-vessel growth from existing vasculature--is an integral part of both normal developmental processes and numerous pathologies such as cancer, ischemic diseases and chronic inflammation. Angiogenesis plays a crucial role facilitating tumour growth and the metastatic process, and it is the result of a dynamic balance between proangiogenic and antiangiogenic factors. The potential to block tumour growth and metastases by angiogenesis inhibition represents an intriguing approach to the cancer treatment. Angiogenesis continues to be a topic of major scientific interest; and there are currently more antiangiogenic drugs in cancer clinical trials than those that fit into any other mechanistic category. Based on preclinical studies, researchers believe that targeting the blood vessels which support tumour growth could help treatment of a broad range of cancers. Angiogenic factors or their receptors, endothelial cell proliferation, matrix metalloproteinases or endothelial cell adhesion, are the main targets of an increasing number of clinical trials approved to test the tolerance and therapeutic efficacy of antiangiogenic agents. Unfortunately, contrary to initial expectations, it has been described tha...Continue Reading

References

Oct 1, 1991·British Journal of Haematology·A EzekowitzJ Folkman
Jan 1, 1987·Nouvelle Revue Française D'hématologie·A Camez, G Tobelem
Sep 1, 1994·Pharmacology & Therapeutics·W Auerbach, R Auerbach
Jan 29, 1999·Cancer Chemotherapy and Pharmacology·G BocciM Del Tacca
Apr 17, 1999·The Journal of Biological Chemistry·M DhanabalV P Sukhatme
Jun 18, 1999·Matrix Biology : Journal of the International Society for Matrix Biology·G M GrantR J Klebe
Aug 7, 1999·Stem Cells·M L RothenbergK R Hande
Aug 5, 2000·International Journal of Cancer. Journal International Du Cancer·F MitjansJ Piulats
Oct 18, 2000·Proceedings of the National Academy of Sciences of the United States of America·A PfeiferI M Verma
Nov 28, 2000·Expert Opinion on Investigational Drugs·W P Steward, A L Thomas
Feb 15, 2001·Biochemical Pharmacology·S LiekensJ Neyts
Mar 20, 2001·Current Oncology Reports·D E Weng, N Usman
Apr 9, 2001·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·M Shichiri, Y Hirata
Nov 15, 2001·International Journal of Clinical Oncology·C H BakerI J Fidler
Jan 5, 2002·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Mary CianfroccaBruce J Dezube
Feb 23, 2002·Science·Joanne L YuRobert S Kerbel
Mar 16, 2002·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Bart C KuenenGiuseppe Giaccone
Apr 12, 2002·Oncogene·Yangfu JiangY Eric Shi
Apr 30, 2002·International Journal of Cancer. Journal International Du Cancer·Pia Vihinen, Veli-Matti Kähäri
Aug 31, 2002·The Oncologist·Malcolm Ranson
Sep 5, 2002·Nature Reviews. Cancer·Christopher Mark Overall, Carlos López-Otín
Mar 20, 2003·Journal of the National Cancer Institute·Zofia von MarschallStefan Rosewicz
Apr 17, 2003·Proceedings of the National Academy of Sciences of the United States of America·Karen S MoultonJudah Folkman
Apr 23, 2003·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·F A L M EskensA T van Oosterom
Jul 29, 2003·Expert Opinion on Investigational Drugs·Ronald M Bukowski
Aug 2, 2003·The New England Journal of Medicine·James C YangSteven A Rosenberg
Nov 7, 2003·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·S StadlmannH Moch

❮ Previous
Next ❯

Citations

Jul 17, 2009·The Journal of Biological Chemistry·Désirée SpieringStephan Ludwig
Mar 21, 2009·Journal of Hypertension·Marek Jankowski
Jan 1, 2009·OncoTargets and Therapy·Luca Toschi, Federico Cappuzzo
Feb 15, 2011·European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Für Pharmazeutische Verfahrenstechnik E.V·Liévin DaugimontVéronique Préat
Jun 16, 2010·Advanced Drug Delivery Reviews·Jonathan R McDanielAshutosh Chilkoti
Aug 25, 2009·Advanced Drug Delivery Reviews·Ehud Segal, Ronit Satchi-Fainaro
May 19, 2010·IEEE/ACM Transactions on Computational Biology and Bioinformatics·Arthur W MahoneyNicholas S Flann
Jan 22, 2010·Biopolymers·Sarah R MacEwan, Ashutosh Chilkoti
Jul 20, 2020·Drug Delivery and Translational Research·Natália N FerreiraMaria Palmira D Gremião
Jan 16, 2021·Antioxidants·Paula Fernández-PalancaJavier González-Gallego

❮ Previous
Next ❯

Related Concepts

Related Feeds

Angiogenesis Inhibitors to Treat Cancer

Cancer treatments including angiogenesis inhibitors prevent tumor cells from receiving nutrients and oxygen. Here is the latest research on angiogenesis inhibitors for the treatment of cancer.